Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 May;93(5):2224–2229. doi: 10.1172/JCI117219

Downregulation of adenylylcyclase types V and VI mRNA levels in pacing-induced heart failure in dogs.

Y Ishikawa 1, S Sorota 1, K Kiuchi 1, R P Shannon 1, K Komamura 1, S Katsushika 1, D E Vatner 1, S F Vatner 1, C J Homcy 1
PMCID: PMC294370  PMID: 8182154

Abstract

We have shown that the heart expresses two distinct forms of adenylylcyclase mRNA, types V and VI. In this study we have characterized the expression of these two mRNA species in heart failure generated by overdrive pacing at a rate of 240 beats/min. After 4 wk, left ventricular end-diastolic pressure and heart rate increased significantly with the appearance of signs of heart failure, i.e., edema, ascites, and exercise intolerance. Basal as well as forskolin-stimulated adenylylcyclase activities decreased significantly, which was accompanied by a reduction in the steady state mRNA levels of adenylylcyclase types V and VI. These data suggest that in this model of cardiomyopathy, the downregulation of adenylylcyclase catalytic activity results, at least in part, from a reduction in the steady state levels of types V and VI adenylylcyclase mRNA levels.

Full text

PDF
2224

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakalyar H. A., Reed R. R. Identification of a specialized adenylyl cyclase that may mediate odorant detection. Science. 1990 Dec 7;250(4986):1403–1406. doi: 10.1126/science.2255909. [DOI] [PubMed] [Google Scholar]
  2. Bell J. D., Buxton I. L., Brunton L. L. Enhancement of adenylate cyclase activity in S49 lymphoma cells by phorbol esters. Putative effect of C kinase on alpha s-GTP-catalytic subunit interaction. J Biol Chem. 1985 Mar 10;260(5):2625–2628. [PubMed] [Google Scholar]
  3. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  4. Bristow M. R., Anderson F. L., Port J. D., Skerl L., Hershberger R. E., Larrabee P., O'Connell J. B., Renlund D. G., Volkman K., Murray J. Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation. 1991 Sep;84(3):1024–1039. doi: 10.1161/01.cir.84.3.1024. [DOI] [PubMed] [Google Scholar]
  5. Bristow M. R., Ginsburg R., Strosberg A., Montgomery W., Minobe W. Pharmacology and inotropic potential of forskolin in the human heart. J Clin Invest. 1984 Jul;74(1):212–223. doi: 10.1172/JCI111404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Calderone A., Bouvier M., Li K., Juneau C., de Champlain J., Rouleau J. L. Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog. Circ Res. 1991 Aug;69(2):332–343. doi: 10.1161/01.res.69.2.332. [DOI] [PubMed] [Google Scholar]
  7. Chen L. A., Vatner D. E., Vatner S. F., Hittinger L., Homcy C. J. Decreased Gs alpha mRNA levels accompany the fall in Gs and adenylyl cyclase activities in compensated left ventricular hypertrophy. In heart failure, only the impairment in adenylyl cyclase activation progresses. J Clin Invest. 1991 Jan;87(1):293–298. doi: 10.1172/JCI114985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cruz F. E., Cheriex E. C., Smeets J. L., Atié J., Peres A. K., Penn O. C., Brugada P., Wellens H. J. Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia. J Am Coll Cardiol. 1990 Sep;16(3):739–744. doi: 10.1016/0735-1097(90)90368-y. [DOI] [PubMed] [Google Scholar]
  9. Federman A. D., Conklin B. R., Schrader K. A., Reed R. R., Bourne H. R. Hormonal stimulation of adenylyl cyclase through Gi-protein beta gamma subunits. Nature. 1992 Mar 12;356(6365):159–161. doi: 10.1038/356159a0. [DOI] [PubMed] [Google Scholar]
  10. Feinstein P. G., Schrader K. A., Bakalyar H. A., Tang W. J., Krupinski J., Gilman A. G., Reed R. R. Molecular cloning and characterization of a Ca2+/calmodulin-insensitive adenylyl cyclase from rat brain. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10173–10177. doi: 10.1073/pnas.88.22.10173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Feldman A. M., Ray P. E., Bristow M. R. Expression of alpha-subunits of G proteins in failing human heart: a reappraisal utilizing quantitative polymerase chain reaction. J Mol Cell Cardiol. 1991 Dec;23(12):1355–1358. doi: 10.1016/0022-2828(91)90182-l. [DOI] [PubMed] [Google Scholar]
  12. Feldman A. M., Ray P. E., Silan C. M., Mercer J. A., Minobe W., Bristow M. R. Selective gene expression in failing human heart. Quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation. 1991 Jun;83(6):1866–1872. doi: 10.1161/01.cir.83.6.1866. [DOI] [PubMed] [Google Scholar]
  13. Feldman M. D., Copelas L., Gwathmey J. K., Phillips P., Warren S. E., Schoen F. J., Grossman W., Morgan J. P. Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation. 1987 Feb;75(2):331–339. doi: 10.1161/01.cir.75.2.331. [DOI] [PubMed] [Google Scholar]
  14. Gao B. N., Gilman A. G. Cloning and expression of a widely distributed (type IV) adenylyl cyclase. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10178–10182. doi: 10.1073/pnas.88.22.10178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gillette P. C., Smith R. T., Garson A., Jr, Mullins C. E., Gutgesell H. P., Goh T. H., Cooley D. A., McNamara D. G. Chronic supraventricular tachycardia. A curable cause of congestive cardiomyopathy. JAMA. 1985 Jan 18;253(3):391–392. doi: 10.1001/jama.253.3.391. [DOI] [PubMed] [Google Scholar]
  16. Gros P., Croop J., Housman D. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell. 1986 Nov 7;47(3):371–380. doi: 10.1016/0092-8674(86)90594-5. [DOI] [PubMed] [Google Scholar]
  17. Hewett K., Legato M. J., Danilo P., Jr, Robinson R. B. Isolated myocytes from adult canine left ventricle: Ca2+ tolerance, electrophysiology, and ultrastructure. Am J Physiol. 1983 Nov;245(5 Pt 1):H830–H839. doi: 10.1152/ajpheart.1983.245.5.H830. [DOI] [PubMed] [Google Scholar]
  18. Heyworth C. M., Whetton A. D., Kinsella A. R., Houslay M. D. The phorbol ester, TPA inhibits glucagon-stimulated adenylate cyclase activity. FEBS Lett. 1984 May 7;170(1):38–42. doi: 10.1016/0014-5793(84)81364-2. [DOI] [PubMed] [Google Scholar]
  19. Homcy C. J., Vatner S. F., Vatner D. E. Beta-adrenergic receptor regulation in the heart in pathophysiologic states: abnormal adrenergic responsiveness in cardiac disease. Annu Rev Physiol. 1991;53:137–159. doi: 10.1146/annurev.ph.53.030191.001033. [DOI] [PubMed] [Google Scholar]
  20. Ishikawa Y., Katsushika S., Chen L., Halnon N. J., Kawabe J., Homcy C. J. Isolation and characterization of a novel cardiac adenylylcyclase cDNA. J Biol Chem. 1992 Jul 5;267(19):13553–13557. [PubMed] [Google Scholar]
  21. Katsushika S., Chen L., Kawabe J., Nilakantan R., Halnon N. J., Homcy C. J., Ishikawa Y. Cloning and characterization of a sixth adenylyl cyclase isoform: types V and VI constitute a subgroup within the mammalian adenylyl cyclase family. Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8774–8778. doi: 10.1073/pnas.89.18.8774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kiuchi K., Shannon R. P., Komamura K., Cohen D. J., Bianchi C., Homcy C. J., Vatner S. F., Vatner D. E. Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest. 1993 Mar;91(3):907–914. doi: 10.1172/JCI116312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Krupinski J., Coussen F., Bakalyar H. A., Tang W. J., Feinstein P. G., Orth K., Slaughter C., Reed R. R., Gilman A. G. Adenylyl cyclase amino acid sequence: possible channel- or transporter-like structure. Science. 1989 Jun 30;244(4912):1558–1564. doi: 10.1126/science.2472670. [DOI] [PubMed] [Google Scholar]
  24. Lemery R., Brugada P., Cheriex E., Wellens H. J. Reversibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable atrial fibrillation. Am J Cardiol. 1987 Dec 1;60(16):1406–1408. doi: 10.1016/0002-9149(87)90633-3. [DOI] [PubMed] [Google Scholar]
  25. Longabaugh J. P., Vatner D. E., Vatner S. F., Homcy C. J. Decreased stimulatory guanosine triphosphate binding protein in dogs with pressure-overload left ventricular failure. J Clin Invest. 1988 Feb;81(2):420–424. doi: 10.1172/JCI113335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Marzo K. P., Frey M. J., Wilson J. R., Liang B. T., Manning D. R., Lanoce V., Molinoff P. B. Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing. Circ Res. 1991 Dec;69(6):1546–1556. doi: 10.1161/01.res.69.6.1546. [DOI] [PubMed] [Google Scholar]
  27. Premont R. T., Chen J., Ma H. W., Ponnapalli M., Iyengar R. Two members of a widely expressed subfamily of hormone-stimulated adenylyl cyclases. Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9809–9813. doi: 10.1073/pnas.89.20.9809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rebois R. V., Patel J. Phorbol ester causes desensitization of gonadotropin-responsive adenylate cyclase in a murine Leydig tumor cell line. J Biol Chem. 1985 Jul 5;260(13):8026–8031. [PubMed] [Google Scholar]
  29. Rommens J. M., Iannuzzi M. C., Kerem B., Drumm M. L., Melmer G., Dean M., Rozmahel R., Cole J. L., Kennedy D., Hidaka N. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989 Sep 8;245(4922):1059–1065. doi: 10.1126/science.2772657. [DOI] [PubMed] [Google Scholar]
  30. Salomon Y. Adenylate cyclase assay. Adv Cyclic Nucleotide Res. 1979;10:35–55. [PubMed] [Google Scholar]
  31. Strittmatter S., Neer E. J. Properties of the separated catalytic and regulatory units of brain adenylate cyclase. Proc Natl Acad Sci U S A. 1980 Nov;77(11):6344–6348. doi: 10.1073/pnas.77.11.6344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Susanni E. E., Manders W. T., Knight D. R., Vatner D. E., Vatner S. F., Homcy C. J. One hour of myocardial ischemia decreases the activity of the stimulatory guanine-nucleotide regulatory protein Gs. Circ Res. 1989 Oct;65(4):1145–1150. doi: 10.1161/01.res.65.4.1145. [DOI] [PubMed] [Google Scholar]
  33. Tang W. J., Gilman A. G. Type-specific regulation of adenylyl cyclase by G protein beta gamma subunits. Science. 1991 Dec 6;254(5037):1500–1503. doi: 10.1126/science.1962211. [DOI] [PubMed] [Google Scholar]
  34. Tang W. J., Krupinski J., Gilman A. G. Expression and characterization of calmodulin-activated (type I) adenylylcyclase. J Biol Chem. 1991 May 5;266(13):8595–8603. [PubMed] [Google Scholar]
  35. Ungerer M., Böhm M., Elce J. S., Erdmann E., Lohse M. J. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation. 1993 Feb;87(2):454–463. doi: 10.1161/01.cir.87.2.454. [DOI] [PubMed] [Google Scholar]
  36. Vatner D. E., Vatner S. F., Fujii A. M., Homcy C. J. Loss of high affinity cardiac beta adrenergic receptors in dogs with heart failure. J Clin Invest. 1985 Dec;76(6):2259–2264. doi: 10.1172/JCI112235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Yoshimasa T., Sibley D. R., Bouvier M., Lefkowitz R. J., Caron M. G. Cross-talk between cellular signalling pathways suggested by phorbol-ester-induced adenylate cyclase phosphorylation. Nature. 1987 May 7;327(6117):67–70. doi: 10.1038/327067a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES